Article | October 12, 2022

How A Pandemic Pushed The Gas Pedal On Patient Centricity In Clinical Trials

Source: Zelta

By Jennifer Duff, General Manager, Clinical Development Solutions

GettyImages-1313298867 cancer patient

Scientific research is challenging. Scientific research on human beings is even more challenging. Factor in a global pandemic that altered nearly every form of human interaction, and you have the perfect storm to drive the clinical trial industry to change course. The good news — perhaps one of the few silver linings to emerge from the COVID-19 pandemic — is that this has largely been a change for the better. Clinical trials are quickly becoming more participant-friendly (and more provider-friendly) through the broader adoption of digital technologies.

access the Article!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Clinical Leader? Subscribe today.

Subscribe to Clinical Leader X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Clinical Leader